{"id":"W4321607274","doi":"10.1111/apt.17351","title":"Editorial: real‐world evidence of tofacitinib and vedolizumab in ulcerative colitis—are we one step closer to better positioning therapies after <scp>anti‐TNF</scp> failure?","year":2023,"lang":"en","type":"editorial","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Alberta Innovates; Leona M. and Harry B. Helmsley Charitable Trust","keywords":"Tofacitinib; Vedolizumab; Medicine; Ulcerative colitis; Colitis; Tumor necrosis factor alpha; Internal medicine; Disease","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006746721,0.00433545,0.003697816,0.003090868,0.002699493,0.005218024,0.003484865,0.01146225,0.01469535],"category_scores_gemma":[0.02070489,0.001175356,0.002604928,0.001182781,0.001767215,0.00345292,0.0009314207,0.01566574,0.01310816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002573701,"about_ca_system_score_gemma":0.002781596,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001297891,"about_ca_topic_score_gemma":0.003444494,"domain_scores_codex":[0.9963986,0.0006245499,0.0005107038,0.0004303631,0.001770847,0.0002648994],"domain_scores_gemma":[0.9874884,0.005056176,0.0007864234,0.0002456535,0.004483017,0.001940334],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007072928,0.00001477148,0.0000284134,0.0001835588,0.00002397356,0.0001637126,0.000008300208,0.00002578785,0.00005426898,0.0001209812,0.9961454,0.003160116],"study_design_scores_gemma":[0.000326084,0.0001031185,0.0005468587,0.0008782025,0.0001983177,0.0009858668,0.00006385964,0.0003442367,0.000320584,0.001322442,0.9948673,0.0000430956],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00006846457,0.002917687,0.0001337754,0.02778772,0.9675351,0.00003012701,0.00008222623,0.00008693265,0.001357962],"genre_scores_gemma":[0.0007315126,0.003347404,0.0001251356,0.02931076,0.95887,0.00003508134,0.00005394327,0.0000557489,0.007470471],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.01469535,"threshold_uncertainty_score":0.04916084,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01898912354164399,"score_gpt":0.3141637851460536,"score_spread":0.2951746616044096,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}